NAPLEX Pain Management Practice Questions with Answers

Concept Explanation

NAPLEX pain management focuses on the clinical application of analgesic guidelines, including opioid conversion, adjuvant therapy selection, and the mitigation of adverse drug events. Pharmacists must demonstrate proficiency in calculating equianalgesic doses, identifying drug-drug interactions, and applying the principles of the CDC Clinical Practice Guideline for Prescribing Opioids to ensure patient safety and therapeutic efficacy. Mastery of this area requires understanding the pharmacokinetics of various formulations, the management of opioid-induced side effects, and the nuances of neuropathic versus nociceptive pain treatment.

For a structured approach to your studies, you can visit our NAPLEX Prep hub for a comprehensive overview of the examination requirements. When managing pain, clinicians often rely on dosage calculations to ensure precision. Additionally, clinical pharmacists utilize the AI Exam Simulator to mimic the actual pressure of the board exam.

Solved Examples

1. Opioid Rotation Calculation: A patient currently taking 60 mg of oral morphine daily is being switched to oral hydromorphone. If the equianalgesic ratio of oral morphine to oral hydromorphone is 5:1, what is the new daily dose of hydromorphone?
   Solution:
   Divide the total daily morphine dose by the ratio:
   $\ \frac{60 \ \text{ mg morphine}}{5} = 12 \ \text{ mg hydromorphone per day}$.
2. Calculating Total Daily Dose (TDD) for Fentanyl Patches: A patient requires a fentanyl transdermal patch equivalent to 100 mg of oral morphine daily. Given that 100 mg of morphine is equivalent to 25 mcg/hr of fentanyl, how many patches are needed if the patient is currently on 200 mg of morphine?
   Solution:
   Calculate the ratio: $\ \frac{200 \ \text{ mg morphine}}{100 \ \text{ mg morphine}} = 2$.
   Multiply the base dose: $2 \ \times 25 \ \text{ mcg/hr} = 50 \ \text{ mcg/hr}$.
3. Morphine Milligram Equivalent (MME) Calculation: Calculate the daily MME for a patient taking 10 mg of hydrocodone four times daily. (Hydrocodone conversion factor is 1).
   Solution:
   Total daily dose of hydrocodone = $10 \ \text{ mg} \ \times 4 = 40 \ \text{ mg}$.
   MME = $40 \ \text{ mg} \ \times 1 = 40 \ \text{ MME/day}$.

Practice Questions

1. A patient is switched from 30 mg oral oxycodone daily to oral morphine. Using a conversion ratio of 1.5:1 (oral morphine:oral oxycodone), what is the total daily dose of morphine?
2. Which medication is the preferred first-line adjuvant for neuropathic pain?
3. A patient is experiencing severe constipation due to chronic opioid use. Which agent is a peripherally acting mu-opioid receptor antagonist (PAMORA) that does not cross the blood-brain barrier?

4. What is the maximum daily dose of acetaminophen recommended for an adult to prevent hepatotoxicity?
5. A patient presents with signs of opioid overdose. What is the mechanism of action of naloxone?
6. Which opioid is associated with the accumulation of a toxic metabolite (normeperidine) that can cause seizures?
7. When converting a patient to transdermal fentanyl, how long does it take for the initial serum concentration to plateau?
8. A patient on chronic buprenorphine therapy requires surgery. How should their pain be managed?

Answers & Explanations

1. 45 mg: $30 \ \text{ mg oxycodone} \ \times 1.5 = 45 \ \text{ mg morphine}$.
2. Pregabalin or Gabapentin: These calcium channel alpha-2-delta ligands are standard first-line treatments for neuropathic conditions.
3. Methylnaltrexone: This agent is specifically designed to treat opioid-induced constipation without reversing central analgesia.
4. 3,000 mg to 4,000 mg: While 4,000 mg is the traditional maximum, many clinical guidelines now suggest 3,000 mg to provide a safety margin against liver injury.
5. Competitive opioid receptor antagonist: Naloxone binds with high affinity to mu-opioid receptors, displacing opioids and reversing respiratory depression.
6. Meperidine: The metabolite normeperidine has a long half-life and is a CNS stimulant, increasing seizure risk.
7. 12 to 24 hours: Fentanyl patches take time to establish a depot in the skin; peak levels are typically reached after 24 hours.
8. Continue buprenorphine and use non-opioid adjuvants or short-acting opioids: Due to high receptor affinity, traditional full-agonist opioids may not work well, requiring careful titration or partial agonist continuation.

1. Which agent is a PAMORA?

• ANaloxone
• BMethylnaltrexone
• CLoperamide
• DMethadone

Frequently Asked Questions

What are the primary risks associated with opioid rotation?

The primary risk is incomplete cross-tolerance, where the patient may be more sensitive to the new opioid than expected. This necessitates a dose reduction of 25-50% during the initial conversion.

Why is acetaminophen limited to 3,000-4,000 mg daily?

Acetaminophen is metabolized into a toxic intermediate, NAPQI, which depletes glutathione stores in the liver. Exceeding recommended doses leads to hepatocyte necrosis and potential liver failure.

Are there specific pain management tools for NAPLEX prep?

Yes, you can use the AI Flashcard Generator to create decks on opioid conversion factors or use the Retrieval Challenge to test your memory of contraindications.

How do you manage opioid-induced hyperalgesia?

Management involves rotating the opioid to a different agent, reducing the current dose, or introducing non-opioid adjuvants like ketamine or NSAIDs to break the cycle of sensitization.

What is the role of NSAIDs in chronic pain?

NSAIDs inhibit COX enzymes to reduce prostaglandin synthesis, effectively treating inflammatory pain. However, they carry risks of GI bleeding, renal impairment, and cardiovascular events.